atomoxetine hydrochloride has been researched along with Stress Disorders, Post-Traumatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamner, M; Myers, US; Wang, Z; Zuschlag, ZD | 1 |
| Adler, LA; Biederman, J; Faraone, SV; Glatt, SJ; Michelson, D; Reimherr, FW; Spencer, TJ | 1 |
2 trial(s) available for atomoxetine hydrochloride and Stress Disorders, Post-Traumatic
| Article | Year |
|---|---|
Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cross-Over Studies; Double-Blind Method; Feasibility Studies; Humans; Propylamines; Quality of Life; Stress Disorders, Post-Traumatic; Treatment Outcome | 2022 |
Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity.
Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Comorbidity; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Health Status; Humans; Male; Mental Disorders; Neuropsychological Tests; Norepinephrine Plasma Membrane Transport Proteins; Placebos; Propylamines; Psychiatric Status Rating Scales; Risk Factors; Stress Disorders, Post-Traumatic; Treatment Outcome | 2006 |